7Baggers
 Shareholders that lost money on Cassava Sciences, Inc.(SAVA) Urg  GuruFocus Sun, 28 Sep 2025 07:18:44 GMT
 Cassava Sciences CEO buys $534K in company stock  MSN Wed, 24 Sep 2025 06:14:59 GMT
 cassava sciences ceo makes bold stock purchase  TipRanks Wed, 24 Sep 2025 02:30:09 GMT
 Cassava Sciences (SAVA) Soars 18% After CEO's Substantial Investment  FinancialContent Tue, 23 Sep 2025 21:03:00 GMT
 cassava boss buys big as stock collapses  TradingView Tue, 23 Sep 2025 16:13:51 GMT
 biggest stock movers tuesday: sava, clsk, plug, and more  Seeking Alpha Tue, 23 Sep 2025 14:16:00 GMT
 biggest stock movers tuesday: sava, clsk, and more  MSN Tue, 23 Sep 2025 09:11:25 GMT
 Cassava Sciences CEO Makes Bold Stock Purchase  TipRanks Tue, 23 Sep 2025 07:00:00 GMT
 cassava sciences (nasdaq:sava) ceo acquires $108,335.32 in stock  MarketBeat Mon, 22 Sep 2025 20:35:39 GMT
 cassava sciences (nasdaq:sava) ceo acquires $427,017.92 in stock  MarketBeat Mon, 22 Sep 2025 07:00:00 GMT
 rosen, a leading law firm, encourages cassava sciences, inc. inv  GuruFocus Wed, 17 Sep 2025 11:03:40 GMT
 cassava sciences files for mixed shelf offering  MSN Wed, 17 Sep 2025 01:53:36 GMT
 cassava sciences files for mixed shelf offering  MSN Tue, 16 Sep 2025 19:18:24 GMT
 Cassava Sciences Releases New Corporate Presentation  TipRanks Mon, 08 Sep 2025 07:00:00 GMT
 cassava sciences reports q2 eps (92c) vs 13c last year  MSN Fri, 05 Sep 2025 06:05:42 GMT
 cassava sciences reports q2 eps (92c) vs 13c last year  MSN Mon, 01 Sep 2025 13:46:37 GMT
 published on: 2025-09-01 04:11:19  Newser Mon, 01 Sep 2025 09:11:19 GMT
 published on: 2025-08-31 22:05:04  Newser Mon, 01 Sep 2025 03:05:04 GMT

Cassava Sciences, Inc
(NASDAQ:SAVA) 

SAVA stock logo

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-b...

Founded: 1998
Full Time Employees: 9
CEO: Remi Barbier  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends